Short Interest in BlackRock Health Sciences Term Trust (NYSE:BMEZ) Rises By 696.9%

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the target of a large increase in short interest in January. As of January 15th, there was short interest totaling 126,819 shares, an increase of 696.9% from the December 31st total of 15,915 shares. Based on an average daily trading volume, of 321,506 shares, the short-interest ratio is currently 0.4 days. Based on an average daily trading volume, of 321,506 shares, the short-interest ratio is currently 0.4 days.

BlackRock Health Sciences Term Trust Stock Performance

NYSE BMEZ traded down $0.18 during trading hours on Wednesday, hitting $15.26. The company had a trading volume of 297,011 shares, compared to its average volume of 369,717. BlackRock Health Sciences Term Trust has a 1-year low of $12.58 and a 1-year high of $16.75. The business has a 50 day moving average of $15.26 and a 200-day moving average of $14.73.

BlackRock Health Sciences Term Trust Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 13th will be given a dividend of $0.11 per share. The ex-dividend date is Friday, March 13th. This represents a c) dividend on an annualized basis and a dividend yield of 8.7%.

Insider Activity at BlackRock Health Sciences Term Trust

In related news, Director Robert W. Fairbairn sold 10,294 shares of BlackRock Health Sciences Term Trust stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $14.98, for a total transaction of $154,204.12. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Institutional Trading of BlackRock Health Sciences Term Trust

Several institutional investors and hedge funds have recently bought and sold shares of BMEZ. Geneos Wealth Management Inc. acquired a new stake in BlackRock Health Sciences Term Trust during the 1st quarter worth $40,000. Allworth Financial LP increased its stake in BlackRock Health Sciences Term Trust by 24,584.6% in the third quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock valued at $46,000 after purchasing an additional 3,196 shares during the period. CWM LLC raised its holdings in shares of BlackRock Health Sciences Term Trust by 25.6% in the fourth quarter. CWM LLC now owns 3,336 shares of the company’s stock valued at $50,000 after buying an additional 680 shares during the last quarter. Newbridge Financial Services Group Inc. acquired a new stake in shares of BlackRock Health Sciences Term Trust during the second quarter worth about $69,000. Finally, Smartleaf Asset Management LLC purchased a new position in shares of BlackRock Health Sciences Term Trust during the third quarter worth about $91,000.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.